Cost Effectiveness in Low- and Middle-Income Countries: A Review of the Debates Surrounding Decision Rules

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.11, 2009-11, pp. : 903-917

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV: A Systematic Review for Low- and Middle-Income Countries

By Galárraga Omar Wirtz Veronika J.

PharmacoEconomics, Vol. 29, Iss. 7, 2011-07 ,pp. : 579-599

Adis International

Access to resources Recommend Favorite

Pharmacovigilance Activities in 55 Low- and Middle-Income Countries: A Questionnaire-Based Analysis

By Olsson Sten

Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. : 689-703

Adis International

Access to resources Recommend Favorite

Global Justice and Health Systems Research in Low‐ and Middle‐Income Countries

THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol. 43, Iss. 1, 2015-03 ,pp. : 143-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emphasizing unique strengths and eliminating redundancy for research in low-income and middle-income countries: Lessons from a South American country

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2668-2670

Blackwell Publishing

Access to resources Recommend Favorite

Teaching Pharmacogenetics in Low and Middle-Income Countries: Team Based Learning and Lessons Learned at the American University of Beirut

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 1, 2011-03 ,pp. : 25-40

Bentham Science Publishers

Access to resources Recommend Favorite